Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amriya Pharmaceutical Industries is a prominent Egyptian pharmaceutical company and a key subsidiary of the Pharco Pharmaceuticals group. Established in 1984 and headquartered in Alexandria, the company specializes in the development and large-scale manufacturing of generic medicines. Its diverse product portfolio addresses various therapeutic areas, including cardiovascular diseases, respiratory conditions, and anti-infectives. Amriya operates modern production facilities that adhere to international Good Manufacturing Practice (GMP) standards, ensuring high-quality and affordable healthcare solutions. The company plays a significant role in the Egyptian domestic market and maintains a strong export presence across the Middle East and Africa. As part of the Pharco group, Amriya leverages extensive distribution networks and research capabilities to maintain its position as a regional leader in the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alamriya.